Picture of Adaptimmune Therapeutics logo

ADAP Adaptimmune Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Adaptimmune Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments89.5368370205147
Net Total Accounts Receivable
Net Total Receivables20.720.73438.146.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets120398415255208
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment51.946.751.471.571.7
Net Intangible Assets
Other Long Term Assets
Total Assets182451470329283
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities34.339.162.564.572.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities57.9110264247243
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity12434120681.939.5
Total Liabilities & Shareholders' Equity182451470329283
Total Common Shares Outstanding